13G Filing: Jim Tananbaum’s Foresite Capital Buys More Shares of Aerie Pharmaceuticals Inc (AERI)

1

NAME OF REPORTING PERSONS Foresite Capital Fund II, L.P. (“FCF II”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_] (b) [X]

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH

5

SOLE VOTING POWER
844,240 shares, except that Foresite Capital Management II, LLC (“FCM II”), the general partner of FCF II, may be deemed to have sole power to vote these shares, and James Tananbaum (“Tananbaum”), the managing member of FCM II, may be deemed to have sole power to vote these shares.

6

SHARED VOTING POWER
See response to row 5.

7

SOLE DISPOSITIVE POWER

844,240 shares, except that FCM II, the general partner of FCF
II, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCM II, may be deemed to
have sole power to dispose of these shares.

8

SHARED DISPOSITIVE POWER
See response to row 7.

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON 844,240

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES [_]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.2%

12

TYPE OF REPORTING PERSON PN

13G Filing: Jim Tananbaum’s Foresite Capital Buys More Shares of Aerie Pharmaceuticals Inc (AERI)

Published on February 22, 2016 at 3:26 pm by Meena Krishnamsetty in Hedge Funds, News

Page 2 of 11 SEC Filing

Follow Aerie Pharmaceuticals Inc (NASDAQ:AERI)

Follow Aerie Pharmaceuticals Inc (NASDAQ:AERI)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on October 30, 2024 at by Inan Dogan, PhD

A New Dawn is Coming to U.S. Stocks

Published on November 16, 2024 at by Insider Monkey Staff